Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants

European Journal of Radiology

Volumn 82, Issue 5, 2013, Pages

  Bargellini, Irene ^a   Bozzi, Elena ^a   Campani, Daniela ^a   Carrai, Paola ^a   De Simone, Paolo ^a   Pollina, Luca ^a   Cioni, Roberto ^a   Filipponi, Franco ^a   Bartolozzi, Carlo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Computed tomography; Hepatocellular carcinoma; Liver transplantation; Therapeutic chemoembolization

Indexed keywords

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR NECROSIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; IMAGE ENHANCEMENT; ITALY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; STATISTICS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84875739274     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2012.12.009     Document Type: Article

References (33)

1. H. Nordenstedt, D.L. White, and H.B. El-Serag The changing pattern of epidemiology in hepatocellular carcinoma Digestive and Liver Disease 42 Suppl 3 2010 S206 S214
2. A. Forner, M.E. Reig, C.R. de Lope, and J. Bruix Current strategy for staging and treatment: the BCLC update and future prospects Seminars in Liver Disease 30 2010 61 74
3. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis New England Journal of Medicine 334 1996 693 699 (Pubitemid 26079803)
4. C.M. Lo, H. Ngan, and W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171 (Pubitemid 34454013)
5. J.M. Llovet, M.I. Real, and X. Montaña Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739 (Pubitemid 34607087)
6. R.J. Lewandowski, L.M. Kulik, and A. Riaz A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization American Journal of Transplantation 9 2009 1920 1928
7. I.W. Graziadei, H. Sandmueller, and P. Waldenberger Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome Liver Transplantation 9 2003 557 563 (Pubitemid 36701690)
8. F.Y. Yao, R.K. Kerlan Jr., and R. Hirose Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 2008 819 827
9. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada Journal of the National Cancer Institute 92 2000 205 216
10. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) European Journal of Cancer 45 2009 228 247
11. A. Forner, C. Ayuso, and M. Varela Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 115 2009 616 623
12. J.M. Llovet, S. Ricci, and V. Mazzaferro SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma New England Journal of Medicine 359 2008 378 390
13. J. Bruix, M. Sherman, and J.M. Llovet EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver Journal of Hepatology 35 2001 421 430 (Pubitemid 32844200)
14. J.M. Llovet, A.M. Di Bisceglie, and J. Bruix Panel of Experts in HCC-Design Clinical Trials. Design and end-points of clinical trials in hepatocellular carcinoma Journal of the National Cancer Institute 100 2008 698 711
15. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Seminars in Liver Disease 30 2010 52 60
16. R. Gillmore, S. Stuart, and A. Kirkwood EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization Journal of Hepatology 55 2011 1309 1311
17. J.H. Shim, H.C. Lee, and S.O. Kim Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models Radiology 262 2012 708 718
18. A. Riaz, R.J. Lewandowski, and L. Kulik Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization Cardiovascular and Interventional Radiology 33 2010 1143 1152
19. A. Riaz, L. Kulik, and R.J. Lewandowski Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres Hepatology 49 2009 1185 1193
20. A. Riaz, K. Memon, and F.H. Miller Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: Radiologic-pathologic correlation Journal of Hepatology 54 2011 695 704
21. S.H. Kim, W.J. Lee, H.K. Lim, and J.H. Lim Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography Journal of Computer Assisted Tomography 31 2007 198 203 (Pubitemid 46573355)
22. A.J. Demetris, R. Jaffe, and T.E. Starzl A review of adult and pediatric post-transplant liver pathology Pathology Annual 22 Pt 2 1987 347 386
23. R. Golfieri, A. Cappelli, and A. Cucchetti Efficacy of selective transarterial chemoembolization in obtaining tumor necrosis in small (<5 cm) hepatocellular carcinomas Hepatology 53 2011 1580 1589
24. J. Lammer, K. Malagari, and T. Vogl PRECISION V Investigators. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovascular and Interventional Radiology 33 2010 41 52
25. Y.S. Kim, H. Rhim, and H.K. Lim Completeness of treatment in hepatocellular carcinomas treated with image-guided tumour therapies: evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen Journal of Computer Assisted Tomography 30 2006 578 582 (Pubitemid 44091511)
26. R. Kloeckner, G. Otto, S. Biesterfeld, K. Oberholzer, C. Dueber, and M.B. Pitton MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma Cardiovascular and Interventional Radiology 33 2010 532 540
27. S. Herber, S. Biesterfeld, and U. Franz Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome Cardiovascular and Interventional Radiology 31 2008 768 777
28. G. Otto, S. Herber, and M. Heise Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma Liver Transplantation 12 2006 1260 1267 (Pubitemid 44194595)
29. I. Bargellini, C. Vignali, and R. Cioni Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria-selection parameter for liver transplantation Radiology 255 2010 289 300
30. A. Riaz, F.H. Miller, and L.M. Kulik Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma JAMA 303 2010 1062 1069
31. S.H. Kim, S.H. Kim, and J. Lee Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma American Journal of Roentgenology 192 2009 1675 1681
32. H. Haradome, L. Grazioli, and R. Tinti Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging Journal of Magnetic Resonance Imaging 34 2011 69 78
33. M. Di Martino, G. De Filippis, and A. De Santis Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging European Radiology 2012 [Epub ahead of print]